111 related articles for article (PubMed ID: 32868973)
1. Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: an observational cohort study.
Dong B; Chen L; Lin W; Su Y; Mao X; Pan D; Ruan G; Xue H; Kang Y; Sun P
Cancer Cell Int; 2020; 20():421. PubMed ID: 32868973
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China.
Ruan G; Song Y; Dong B; Mao X; Lin F; Kang Y; Xu S; Chen X; Wu Q; Sun P
Cancer Manag Res; 2018; 10():3227-3235. PubMed ID: 30233239
[TBL] [Abstract][Full Text] [Related]
3. Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study.
Dong B; Zou H; Mao X; Su Y; Gao H; Xie F; Lv Y; Chen Y; Kang Y; Xue H; Pan D; Sun P
Ther Adv Med Oncol; 2021; 13():17588359211010939. PubMed ID: 33995595
[TBL] [Abstract][Full Text] [Related]
4. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
[TBL] [Abstract][Full Text] [Related]
5. Clinical validation of the Cervista
Mao X; Ruan G; Dong B; Chen L; Xu S; Lin F; Sun P
Ther Clin Risk Manag; 2018; 14():2243-2253. PubMed ID: 30532547
[TBL] [Abstract][Full Text] [Related]
6. Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.
Liang LA; Einzmann T; Franzen A; Schwarzer K; Schauberger G; Schriefer D; Radde K; Zeissig SR; Ikenberg H; Meijer CJLM; Kirkpatrick CJ; Kölbl H; Blettner M; Klug SJ
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):474-484. PubMed ID: 33187968
[TBL] [Abstract][Full Text] [Related]
7. Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results.
Xue H; Gao H; Zheng J; Chen Y; Chen J; Pan D; Dong B; Sun P
J Cancer; 2021; 12(14):4332-4340. PubMed ID: 34093833
[No Abstract] [Full Text] [Related]
8. Performance of the Human Papillomavirus E6/E7 mRNA Assay in the Primary Screening of Cervical Cancer: Opportunistic Screening in Fujian, China.
Zhuang L; Weng X; Wang L; Xie X; Zhong L; Liu D; Xiu Y
Int J Womens Health; 2022; 14():1519-1530. PubMed ID: 36317009
[TBL] [Abstract][Full Text] [Related]
9. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.
Kitchener HC; Almonte M; Gilham C; Dowie R; Stoykova B; Sargent A; Roberts C; Desai M; Peto J;
Health Technol Assess; 2009 Nov; 13(51):1-150, iii-iv. PubMed ID: 19891902
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Seeplex HPV4A ACE and the Cervista HPV assays for the detection of HPV in hybrid capture 2 positive media.
Min KJ; So KA; Lee J; Hong HR; Hong JH; Lee JK; Kim AR
J Gynecol Oncol; 2012 Jan; 23(1):5-10. PubMed ID: 22355460
[TBL] [Abstract][Full Text] [Related]
11. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the cervista HPV HR test and luminex XMAP technology for the diagnosis of cervical intraepithelial neoplasia.
Zhao PY; Jiang HC; Li Y; Wang JB; Zhang TT; Liu CH; Song LW; Cheng JJ
Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():150-155. PubMed ID: 28535400
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
14. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
16. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
Wentzensen N; Fetterman B; Castle PE; Schiffman M; Wood SN; Stiemerling E; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
J Natl Cancer Inst; 2015 Dec; 107(12):djv257. PubMed ID: 26376685
[TBL] [Abstract][Full Text] [Related]
17. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
Ge Y; Christensen PA; Luna E; Armylagos D; Xu J; Hsu JW; Zhou H; Schwartz MR; Mody DR
Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the performance of three different cervical cancer screening modalities in a large prospective population-based cohort.
Song F; Du H; Xiao A; Wang C; Huang X; Liu Z; Zhao M; Men H; Wu R
J Infect Public Health; 2020 Nov; 13(11):1780-1786. PubMed ID: 32919932
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women.
Granados R; Tellez-Safina H; Solis I; Mateos F; Rodriguez-Barbero JM; Aramburu JA; Huertas MA; Bajo P; Camarmo E; Corrales T; Medina P; Calvo B; Martin E; Anta L; Zamora M; Alcaide T
Diagn Cytopathol; 2017 Dec; 45(12):1065-1072. PubMed ID: 28949442
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
